California · Nonprofit
AIM AT MELANOMA
AIM AT MELANOMA (California) receives grants from 47 organizations whose IRS filings report $539,657 to it, the largest being NATIONAL PHILANTHROPIC TRUST ($90,000). 18 of them have funded it in more than one year, and 64% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2025
- $2.7M
- Funders on record
- 47
- Grants received
- $540k
- Net assets
- $7.3M
What Aim at Melanoma does
Mission
Aim at Melanoma (aim) is globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education, and patient and caregiver support. Founded in 2004, Aim at Melanoma is the largest international melanoma foundation seeking the cure for melanoma. Aim believes that the cure for melanoma will be found more quickly by bringing together leading global researchers and funding their collaborative research. Our three paradigm-shifting global research initiatives, including the melanoma tissue bank consortium, are poised to reshape the future of melanoma. Aim is the respected voice of melanoma across the nation. When drugs are approved, legislation is drafted, and research is assessed, aim is at the table, speaking loudly and clearly on behalf of patients and their families. Aim is the trusted advisor for pharmaceutical companies, medical boards, and government agencies on critical topics that affect melanoma patients.
As stated on its FY2025 Form 990.
Programs
WebsiteAim at Melanoma ("aim") is the largest international organization engaged in a wide range of global patient advocacy initiatives for the purpose of raising awareness about melanoma and supporting those impacted by the disease by providing comprehensive education, advocating for patients and their families, and funding collaborative research initiatives. Among our most important contributions to the melanoma community is the ownership and maintenance of the most comprehensive u.s. Website on melanoma (www.aimatmelanoma.org). In 2025, aim continued to create website content for the purpose of meeting the needs of the melanoma community. This included, but was not limited to, making it easier for users to identify pertinent information to assist them in better understanding their melanoma diagnosis and staging, treatment options, clinical trial opportunities, recognition and management of the side effects of treatment, risk of recurrence, follow-up care, and the psychosocial aspects of the disease. The organization continued to use various methods, such as search engine optimization, social media, and brochures distributed to healthcare providers throughout the u.s, and other…
$1,838,518 spentof which $295,000 as grants$10,100 earned by the program100% of program spendingContinued line 4a from schedule ocancer institute; the peter maccallum cancer center and alfred hospital in melbourne are signed on to participate but have not begun collecting tissue. The tissue bank is the fundamental research tool that does not exist yet for public or private research. Major advances, particularly within breast and prostate cancer, resulted from similar banks. Consequently, melanoma research lags significantly behind the progress that has been made in other cancer research. In 2025, the bank collected a total of 24 tissues from u.s. Sites and continued its effort to start collecting tissue at its australian sites. Wimin august 2017, aim formed women in melanoma (wim). With a growing number of young women oncologists with an interest in melanoma, and aim's proven track record for bringing together melanoma experts, aim formed wim for the purpose of supporting the improvement of melanoma patient outcomes through a focus on strengthening the physician-patient relationship, providing insights into best practices in communicating with patients with melanoma to improve outcome, supporting the academic careers of young women with a research interest in melanoma, and…
The 2 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $1,838,518.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $3.7M to $4.7M (+28%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
97% of AIM AT MELANOMA’s revenue is contributions — more reliant on donations than three-quarters of its peers (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2023: the base broadened from 7 funders to 19 funders, grant income rose $21k → $99k.
12 of 47 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 64% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of AIM AT MELANOMA’s funders (the co-funder graph). Top 30 of 47 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
AIM AT MELANOMA has a broad base — no single funder exceeds 17% of grant income, and it takes 4 funders to reach half.
the vertical line marks half of all grant income — 4 funders to its left
68% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund AIM AT MELANOMA.
Largest funder’s share by year: 2017 48% · 2018 71% · 2019 54% · 2020 28% · 2021 28% · 2022 43% · 2023 20% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
35% of AIM AT MELANOMA's funders are still giving 3 years after their first grant; 38% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
64% of AIM AT MELANOMA's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $193k that is directly attributable, 95% of it comes from funders outside California, across 19 states.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $347k arriving through sponsors registered in 10 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
AIM AT MELANOMA runs a healthier operating margin than three-quarters of the 5,002 health nonprofits its size.
this organization peer median middle 50% of peers· 5,002 health nonprofits $1M–$10M, FY2025
Organizations like AIM AT MELANOMA
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In California
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
89% of spending goes to programs.
Governance
Public support
52%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for AIM AT MELANOMA: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds AIM AT MELANOMA?
- AIM AT MELANOMA (California) receives grants from 47 organizations whose IRS filings report $539,657 to it, the largest being NATIONAL PHILANTHROPIC TRUST ($90,000). 18 of them have funded it in more than one year, and 64% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does AIM AT MELANOMA have?
- IRS filings report 47 organizations giving $539,657 in grants to AIM AT MELANOMA, 18 of which have funded it in more than one year.
- Who is the largest funder of AIM AT MELANOMA?
- NATIONAL PHILANTHROPIC TRUST is the largest funder on record, with $90,000 in grants. The full list of funders is on this page.
- How can an organization like AIM AT MELANOMA find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 47 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing